biote Corp. (BTMD): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$58.54M
As of 2025-12-31
-$65.79M
As of 2026-06-30
$4.12M2020-12-31: $25.0K2021-12-31: $4.12M2022-12-31: -$44.46M2023-12-31: -$29.40M2024-12-31: -$105.93M2025-12-31: -$58.54M-$58.54M
2020-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$58.54Mn/m2026-03-13, Balance as of period end
2024-12-31-$105.93Mn/m2026-03-13, Balance as of period end
2023-12-31-$29.40Mn/m2025-03-14, Balance as of period end
2022-12-31-$44.46Mn/m2024-03-15, Balance as of period end
2021-12-31$4.12Mn/m2023-03-29, Balance as of period end
2020-12-31$25.0Kn/a2022-04-07, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
biote Corp. (BTMD)2025-12-31-$58.54Mn/m
Glass House Brands Inc. (GLAS)2025-12-31$73.94M-36.4%
Marimed Inc. (MRMD)2025-12-31$50.01M-14.6%
Cronos Group Inc. (CRON)2025-12-31$1.14B+2.9%
Natural Alternatives International Inc (NAII)2026-06-30$49.96M-27.0%
Jushi Holdings Inc. (JUSH)2025-12-31-$115.34Mn/m
Niagen Bioscience, Inc. (NAGE)2025-12-31$76.53M+66.0%
Mannatech Inc (MTEX)2025-12-31-$5.22Mn/m
Fitlife Brands, Inc. (FTLF)2025-12-31$43.64M+20.8%

Compare BTMD, GLAS, MRMD, CRON side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗